Latest filing published 19 Oct 2023 for China Pharma Holdings, INC., €1.8M.
Insider track record
Zhilin Li: trading record in brief
Zhilin Li discloses dealings in China Pharma Holdings, Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 13 September 2006 to 29 September 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 19 October 2023: a share grant of €1.8M, in China Pharma Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Zhilin Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,757,063 shares@ US$0.1464.6% of flowCommon StockSEC:0001013762-23-005114:0
- 1,760,000 shares@ US$0.6735.4% of flowCommon StockSEC:0001213900-21-047830:0
- 2,000,000 shares0Common StockSEC:0001213900-21-001170:0
- 50,000 shares0Common StockSEC:0001010549-11-000528:0
- 10,000,000 sharesCommon Stock, par value $0.001 per shareSEC:0001010549-06-000619:0
5 of 5 declarations